Position in ACET
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$312,958
+$66,287 QoQ
Shares Held
36,222
0.0% QoQ
Ownership
0.387%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 56 holders
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 59%
Shared 0%
None 41%
Common Shares in ACET Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026STATE STREET CORP holds $36,552,510,511 across 411 Biotechnology names. ACET ranks #318 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,871,459 | $5,896,909,829 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,834,688 | $3,014,621,355 | |
| 3 | INCY |
Incyte Corp
|
9,722,336 | $1,102,124,008 | |
| 4 | MRNA |
Moderna, Inc.
|
15,726,193 | $1,101,305,295 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,555,689 | $1,070,369,059 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
4,897,051 | $917,119,711 | |
| 7 | RPRX |
Royalty Pharma plc
|
12,338,229 | $691,804,500 | |
| 8 | INSM |
INSMED Inc
|
6,052,174 | $645,282,791 |
All Filings in ACET
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $312,958 | 36,222 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $246,671 | 36,222 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $218,044 | 25,896 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $197,790 | 244,186 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $150,621 | 246,921 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $186,425 | 246,921 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $237,538 | 246,921 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $330,798 | 229,721 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $296,233 | 244,821 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,209,549 | 940,234 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,210,626 | 640,543 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $867,940 | 633,533 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,369,946 | 563,764 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $3,251,272 | 564,457 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $20,424,198 | 2,284,586 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $27,846,528 | 1,958,265 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $6,947,497 | 475,856 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,923,456 | 396,768 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,726,943 | 327,441 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,322,576 | 296,247 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,584,817 | 251,197 | Shares | Defined | 2021-08-16 | |
| 2020-12-31 | $217,297 | 15,466 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $183,890 | 15,466 | Shares | Defined | 2020-11-10 | |
| No filing history on record for this holder in this stock. | ||||||